Stock FAE FAES FARMA, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Company Faes Farma, S.A.

Equities

FAE

ES0134950F36

Pharmaceuticals

Market Closed - BME
Other stock markets
 11:35:00 2024-04-23 am EDT 		After market 01:27:20 pm
3.285 EUR +3.30% Intraday chart for Faes Farma, S.A. 3.29 +0.15%
Feb. 27 FAES FARMA : Q4 profitability exceeded expectations Alphavalue
Feb. 27 Faes Farma, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company’s research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The Company operates in Spain, Portugal, Chile and Mexico, among others. It controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.

Number of employees: 1,748

Sales per Business

EUR in Million2022Weight2023Weight Delta
Pharmaceutical Specialties and Healthcare
87.6 %
378 86.1 % 395 87.6 % +4.56%
Nutrition and Animal Health
11.6 %
59 13.5 % 53 11.6 % -11.35%
Others
0.8 %
2 0.4 % 4 0.8 % +116.27%

Sales per region

EUR in Million2022Weight2023Weight Delta
International
55.0 %
128 29.2 % 248 55.0 % +94.06%
Spain
45.0 %
311 70.8 % 203 45.0 % -34.72%

Managers

Managers TitleAgeSince
Gonzalo López Casanueva CEO
 Chief Executive Officer - -
Francisco Quintanilla Guerra CEO
 Chief Executive Officer - -
Valentín Ruiz Unamunzaga DFI
 Director of Finance/CFO - -
Mariano Ucar Angulo CHM
 Chairman - 91-05-15
Lourdes Azcárate Goiri CTO
 Chief Tech/Sci/R&D Officer - -
Gonzalo Fernández de Valderrama BRD
 Director/Board Member - 03-06-23
Mariana Soroa Zubiria AUD
 Comptroller/Controller/Auditor - -
Germán Fernández-Cano Díaz SAM
 Sales & Marketing - -

Members of the board

Members of the board TitleAgeSince
Maria Belén Amatriain Corbi BRD
 Director/Board Member 65 18-06-18
Mariano Ucar Angulo CHM
 Chairman - 91-05-15
Iñigo Zavala Ortiz de la Torre BRD
 Director/Board Member - 94-06-25
Gonzalo Fernández de Valderrama BRD
 Director/Board Member - 03-06-23
Carmen Basagoiti Pastor BRD
 Director/Board Member - 11-07-19
Nuria Pascual Lapeña BRD
 Director/Board Member 61 22-06-21
Carlos de Alcocer Torra BRD
 Director/Board Member - 13-06-24
Enrique Linares Plaza BRD
 Director/Board Member - 22-06-21
María Eugenia Zugaza Salazar BRD
 Director/Board Member - 19-06-18
Belén Amatriain Corbi
66 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 316,223,938 288,164,344 ( 91.13 %) 4,975,247 ( 1.573 %) 91.13 %

Shareholders

NameEquities%Valuation
Indumenta Pueri SL
4.914 %
15,539,782 4.914 % 53 M €
Alantra EQMC Asset Management SGIIC SA
3.015 %
9,533,898 3.015 % 32 M €
Norges Bank Investment Management
2.934 %
9,278,813 2.934 % 32 M €
Argenta Spaarbank NV
1.107 %
3,501,611 1.107 % 12 M €
Iñigo Zavala Ortiz de la Torre
0.7568 %
2,393,028 0.7568 % 8 M €
Caixabank Asset Management SGIIC SA
0.5945 %
1,879,827 0.5945 % 6 M €
Serafin Asset Management AG
0.5270 %
1,666,343 0.5270 % 6 M €
Mariano Ucar Angulo
0.4717 %
1,491,758 0.4717 % 5 M €
Praude Asset Management Ltd.
0.3932 %
1,243,318 0.3932 % 4 M €
Carlos de Alcocer Torra
0.3243 %
1,025,583 0.3243 % 3 M €

Company contact information

Faes Farma SA

Avenida Autonomia, 10

48940, Leioa

+34 944 81 83 00

http://faesfarma.com
address Faes Farma, S.A.(FAE)

Group companies

NameCategory and Sector
Faes Farma México SA de CV
Lazlo International SA

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Faes Farma, S.A.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
3.18 EUR
Average target price
3.708 EUR
Spread / Average Target
+16.59%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
FAES FARMA, S.A. Stock Faes Farma, S.A.
+3.96% 1.05B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+27.15% 659B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.68% 557B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.32% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.57% 322B
ABBVIE INC. Stock AbbVie Inc.
+9.80% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+6.30% 215B
NOVARTIS AG Stock Novartis AG
+4.80% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-6.05% 200B
PFIZER, INC. Stock Pfizer, Inc.
-8.81% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. FAE Stock
  4. Company Faes Farma, S.A.